Naveed Sadiq, Amray Afshan Naz, Jahan Nusrat, Moti-Wala Fatima Bilal, Majeed Muhammad Hassan
Dr. Naveed is with the University of Kansas Medical Center in Kansas City, Kansas.
Dr. Amray is with Dow University of Health Sciences in Karachi, Pakistan.
Innov Clin Neurosci. 2019 Sep 1;16(9-10):36-43.
Anxiety disorders are the most prevalent psychiatric disorders among youth, with prevalence rates ranging from 25 to 32 percent. These disorders are under-recognized and often undertreated in this population. Anxiety disorders in youth exhibit a chronic and persistent course of symptoms with a higher risk of comorbidities, functional impairment, and worsening of severity. The early recognition and treatment of anxiety disorders in children and adolescents are vital for better long-term outcomes. This article summarizes the evidence-based pharmacologic treatments for mixed anxiety disorders including generalized anxiety disorder, social anxiety disorder, and separation anxiety disorder in children and adolescents based on case reports, case series, open-label trials, and randomized, controlled trials.
焦虑症是青少年中最普遍的精神疾病，患病率在25%至32%之间。这些疾病在这一人群中未得到充分认识，且往往治疗不足。青少年焦虑症表现出慢性和持续性的症状过程，合并症、功能损害和病情加重的风险更高。儿童和青少年焦虑症的早期识别和治疗对于获得更好的长期预后至关重要。本文基于病例报告、病例系列、开放标签试验以及随机对照试验，总结了针对儿童和青少年混合性焦虑症（包括广泛性焦虑症、社交焦虑症和分离焦虑症）的循证药物治疗方法。
